Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Flow cytometry in Barrett's esophagus. What have we learned so far?

Literature DB >> 2022154

Flow cytometry in Barrett's esophagus. What have we learned so far?

H S Garewal, R E Sampliner, M B Fennerty.

Abstract

Mesh：

Substances：
DNA

Year: 1991 PMID： 2022154 DOI： 10.1007/bf01297017

Source DB: PubMed Journal: Dig Dis Sci ISSN： 0163-2116 Impact factor: 3.199

× No keyword cloud information.

12 in total

1. Chronic peptic ulcer of the oesophagus and 'oesophagitis'.

Authors: N R BARRETT
Journal: Br J Surg Date: 1950-10 Impact factor: 6.939

2. Observer variation in the diagnosis of dysplasia in Barrett's esophagus.

Authors: B J Reid; R C Haggitt; C E Rubin; G Roth; C M Surawicz; G Van Belle; K Lewin; W M Weinstein; D A Antonioli; H Goldman
Journal: Hum Pathol Date: 1988-02 Impact factor: 3.466

3. Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus.

Authors: M B Fennerty; R E Sampliner; D Way; R Riddell; K Steinbronn; H S Garewal
Journal: Gastroenterology Date: 1989-10 Impact factor: 22.682

4. Barrett's esophagus: a model premalignant lesion for adenocarcinoma.

Authors: H S Garewal; R Sampliner
Journal: Prev Med Date: 1989-09 Impact factor: 4.018

5. Adenocarcinoma and Barrett's esophagus. An overrated risk?

Authors: S J Spechler; A H Robbins; H B Rubins; M E Vincent; T Heeren; W G Doos; T Colton; E M Schimmel
Journal: Gastroenterology Date: 1984-10 Impact factor: 22.682

6. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma.

Authors: B J Reid; R C Haggitt; C E Rubin; P S Rabinovitch
Journal: Gastroenterology Date: 1987-07 Impact factor: 22.682

2. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets.

Authors: B J Reid; D S Levine; G Longton; P L Blount; P S Rabinovitch
Journal: Am J Gastroenterol Date: 2000-07 Impact factor: 10.864

Review 3. Barrett's esophagus.

Authors: A Ertan; M Younes
Journal: Dig Dis Sci Date: 2000-08 Impact factor: 3.199

3 in total

Flow cytometry in Barrett's esophagus. What have we learned so far?

1. Chronic peptic ulcer of the oesophagus and 'oesophagitis'.

2. Observer variation in the diagnosis of dysplasia in Barrett's esophagus.

3. Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus.

4. Barrett's esophagus: a model premalignant lesion for adenocarcinoma.

5. Adenocarcinoma and Barrett's esophagus. An overrated risk?

6. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma.

7. DNA content in Barrett's esophagus and esophageal malignancy.

8. Prognostic implications of ploidy and proliferative activity in human solid tumors.

9. Value of DNA image cytometry in the prediction of malignant change in Barrett's oesophagus.

Review 10. DNA content in human cancer. Application in pathology and clinical medicine.

1. Flow cytometry and Barrett's esophagus.

2. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets.

Review 3. Barrett's esophagus.